{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:18:12Z","timestamp":1788952692291,"version":"build-2803163510"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,15]]},"DOI":"10.7759\/cureus.50577","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T14:55:36Z","timestamp":1702652136000},"source":"Crossref","is-referenced-by-count":3,"title":["Overview of the Association Between the Pathophysiology, Types, and Management of Sickle Cell Disease and Stroke"],"prefix":"10.7759","author":[{"given":"Faisal","family":"Hakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essam","family":"Alhazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa M","family":"Busayli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Althurwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman  M","family":"Darraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A","family":"Alamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyaj","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renad A","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal I","family":"Moafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan A","family":"Mahasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ali","family":"Madkhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20336","article-title":"Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance","volume":"79","author":"Ballas SK","year":"2005","unstructured":"Ballas SK, Lusardi M. Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am J Hematol. 2005, 79:17-25. 10.1002\/ajh.20336","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt OS","year":"1994","unstructured":"Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994, 330:1639-1644. 10.1056\/NEJM199406093302303","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors","volume":"325","author":"Platt OS","year":"1991","unstructured":"Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991, 325:11-16. 10.1056\/NEJM199107043250103","journal-title":"N Engl J Med"},{"key":"ref4","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong K","year":"1998","unstructured":"Ohene-Frempong K, Weiner SJ, Sleeper LA, et al.. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998, 91:288-294.","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1985.02140130058030","article-title":"Intracranial hemorrhage in children with sickle cell disease","volume":"139","author":"Van Hoff J","year":"1985","unstructured":"Van Hoff J, Ritchey AK, Shaywitz BA. Intracranial hemorrhage in children with sickle cell disease. Am J Dis Child. 1985, 139:1120-1123. 10.1001\/archpedi.1985.02140130058030","journal-title":"Am J Dis Child"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-272682","article-title":"Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia","volume":"119","author":"DeBaun MR","year":"2012","unstructured":"DeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood. 2012, 119:4587-4596. 10.1182\/blood-2011-02-272682","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware RE","year":"2017","unstructured":"Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. Lancet. 2017, 390:311-323. 10.1016\/S0140-6736(17)30193-9","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-120611-143127","article-title":"Sickle cell disease, vasculopathy, and therapeutics","volume":"64","author":"Kassim AA","year":"2013","unstructured":"Kassim AA, DeBaun MR. Sickle cell disease, vasculopathy, and therapeutics. Annu Rev Med. 2013, 64:451-466. 10.1146\/annurev-med-120611-143127","journal-title":"Annu Rev Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/10739680490278402","article-title":"The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy","volume":"11","author":"Hebbel RP","year":"2004","unstructured":"Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy. Microcirculation. 2004, 11:129-151. 10.1080\/10739680490278402","journal-title":"Microcirculation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.07.011","article-title":"Hypercoagulability in sickle cell disease: a curious paradox","volume":"115","author":"Ataga KI","year":"2003","unstructured":"Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: a curious paradox. Am J Med. 2003, 115:721-728. 10.1016\/j.amjmed.2003.07.011","journal-title":"Am J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams RJ","year":"1998","unstructured":"Adams RJ, McKie VC, Hsu L, et al.. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998, 339:5-11. 10.1056\/NEJM199807023390102","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-618579","article-title":"Central nervous system complications and management in sickle cell disease","volume":"127","author":"DeBaun MR","year":"2016","unstructured":"DeBaun MR, Kirkham FJ. Central nervous system complications and management in sickle cell disease. Blood. 2016, 127:829-838. 10.1182\/blood-2015-09-618579","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba3827","article-title":"Treating sickle cell anemia","volume":"367","author":"Tisdale JF","year":"2020","unstructured":"Tisdale JF, Thein SL, Eaton WA. Treating sickle cell anemia. Science. 2020, 367:1198-1199. 10.1126\/science.aba3827","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1126\/science.110.2865.543","article-title":"Sickle cell anemia a molecular disease","volume":"110","author":"Pauling L","year":"1949","unstructured":"Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia a molecular disease. Science. 1949, 110:543-548. 10.1126\/science.110.2865.543","journal-title":"Science"},{"key":"ref15","article-title":"Sickle Cell Trait","author":"Ashorobi D","year":"2023","unstructured":"Ashorobi D, Ramsey A, Yarrarapu SNS, Bhatt R. Sickle Cell Trait. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/178792a0","article-title":"A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin","volume":"178","author":"Ingram VM","year":"1956","unstructured":"Ingram VM. A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature. 1956, 178:792-794. 10.1038\/178792a0","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees DC","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010, 376:2018-2031. 10.1016\/S0140-6736(10)61029-X","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-498311","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies","volume":"122","author":"Manwani D","year":"2013","unstructured":"Manwani D, Frenette PS. Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. Blood. 2013, 122:3892-3898. 10.1182\/blood-2013-05-498311","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions","volume":"84","author":"Kato GJ","year":"2009","unstructured":"Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT. Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol. 2009, 84:618-625. 10.1002\/ajh.21475","journal-title":"Am J Hematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196910232811703","article-title":"Functional asplenia in sickle-cell anemia","volume":"281","author":"Pearson HA","year":"1969","unstructured":"Pearson HA, Spencer RP, Cornelius EA. Functional asplenia in sickle-cell anemia. N Engl J Med. 1969, 281:923-926. 10.1056\/NEJM196910232811703","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035237","article-title":"Understanding sickle cell disease: causes, symptoms, and treatment options","volume":"102","author":"Elendu C","year":"2023","unstructured":"Elendu C, Amaechi DC, Alakwe-Ojimba CE, et al.. Understanding sickle cell disease: causes, symptoms, and treatment options. Medicine (Baltimore). 2023, 102:e35237. 10.1097\/MD.0000000000035237","journal-title":"Medicine (Baltimore)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato GJ","year":"2018","unstructured":"Kato GJ, Piel FB, Reid CD, et al.. Sickle cell disease. Nat Rev Dis Primers. 2018, 4:18011. 10.1038\/nrdp.2018.10","journal-title":"Nat Rev Dis Primers"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato GJ","year":"2007","unstructured":"Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007, 21:37-47. 10.1016\/j.blre.2006.07.001","journal-title":"Blood Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2007.1.91","article-title":"Hypercoagulability in sickle cell disease: new approaches to an old problem","author":"Ataga KI","year":"2007","unstructured":"Ataga KI, Key NS. Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program. 2007, 91-96. 10.1182\/asheducation-2007.1.91","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang D","year":"2016","unstructured":"Zhang D, Xu C, Manwani D, Frenette PS. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood. 2016, 127:801-809. 10.1182\/blood-2015-09-618538","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101690","article-title":"Vaso-occlusion in sickle cell disease: is autonomic dysregulation of the microvasculature the trigger?","volume":"8","author":"Veluswamy S","year":"2019","unstructured":"Veluswamy S, Shah P, Denton CC, Chalacheva P, Khoo MC, Coates TD. Vaso-occlusion in sickle cell disease: is autonomic dysregulation of the microvasculature the trigger?. J Clin Med. 2019, 8:1690. 10.3390\/jcm8101690","journal-title":"J Clin Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2015.05.013","article-title":"Cardiomyopathy with restrictive physiology in sickle cell disease","volume":"9","author":"Niss O","year":"2016","unstructured":"Niss O, Quinn CT, Lane A, et al.. Cardiomyopathy with restrictive physiology in sickle cell disease. JACC Cardiovasc Imaging. 2016, 9:243-252. 10.1016\/j.jcmg.2015.05.013","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel FB","year":"2013","unstructured":"Piel FB, Patil AP, Howes RE, et al.. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013, 381:142-151. 10.1016\/S0140-6736(12)61229-X","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011783","article-title":"The natural history of sickle cell disease","volume":"3","author":"Serjeant GR","year":"2013","unstructured":"Serjeant GR. The natural history of sickle cell disease. Cold Spring Harb Perspect Med. 2013, 3:a011783. 10.1101\/cshperspect.a011783","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa: a neglected cause of early childhood mortality","volume":"41","author":"Grosse SD","year":"2011","unstructured":"Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med. 2011, 41:S398-S405. 10.1016\/j.amepre.2011.09.013","journal-title":"Am J Prev Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell KL","year":"2010","unstructured":"Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010, 38:S512-S521. 10.1016\/j.amepre.2009.12.022","journal-title":"Am J Prev Med"},{"key":"ref32","article-title":"Sickle Cell Anemia","author":"Mangla A","year":"2023","unstructured":"Mangla A, Ehsan M, Agarwal N, Maruvada S. Sickle Cell Anemia. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3758","article-title":"Survival of children with sickle cell disease","volume":"103","author":"Quinn CT","year":"2004","unstructured":"Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood. 2004, 103:4023-4027. 10.1182\/blood-2003-11-3758","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.81540","article-title":"Epidemiology of sickle cell disease in Saudi Arabia","volume":"31","author":"Jastaniah W","year":"2011","unstructured":"Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med. 2011, 31:289-293. 10.4103\/0256-4947.81540","journal-title":"Ann Saudi Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.2.776.bloodjournal862776","article-title":"Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative study of sickle cell disease","volume":"86","author":"Gill FM","year":"1995","unstructured":"Gill FM, Sleeper LA, Weiner SJ, et al.. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative study of sickle cell disease. Blood. 1995, 86:776-783. 10.1182\/blood.V86.2.776.bloodjournal862776","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079923","article-title":"Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study","volume":"8","author":"Darbari DS","year":"2013","unstructured":"Darbari DS, Wang Z, Kwak M, et al.. Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study. PLoS One. 2013, 8:e79923. 10.1371\/journal.pone.0079923","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnma.2020.01.001","article-title":"Sickle cell disease is associated with increased morbidity, resource utilization, and readmissions after common abdominal surgeries: a multistate analysis, 2007-2014","volume":"112","author":"Brumm J","year":"2020","unstructured":"Brumm J, White RS, Arroyo NS, Gaber-Baylis LK, Gupta S, Turnbull ZA, Mehta N. Sickle cell disease is associated with increased morbidity, resource utilization, and readmissions after common abdominal surgeries: a multistate analysis, 2007-2014. J Natl Med Assoc. 2020, 112:198-208. 10.1016\/j.jnma.2020.01.001","journal-title":"J Natl Med Assoc"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001133420203","article-title":"Prediction of adverse outcomes in children with sickle cell disease","volume":"342","author":"Miller ST","year":"2000","unstructured":"Miller ST, Sleeper LA, Pegelow CH, et al.. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000, 342:83-89. 10.1056\/NEJM200001133420203","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-019-00162-5","article-title":"Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach","volume":"10","author":"Polivka J Jr","year":"2019","unstructured":"Polivka J Jr, Polivka J, Pesta M, et al.. Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach. EPMA J. 2019, 10:81-99. 10.1007\/s13167-019-00162-5","journal-title":"EPMA J"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group","volume":"342","author":"Vichinsky EP","year":"2000","unstructured":"Vichinsky EP, Neumayr LD, Earles AN, et al.. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000, 342:1855-1865. 10.1056\/NEJM200006223422502","journal-title":"N Engl J Med"},{"key":"ref41","article-title":"Acute Chest Syndrome","author":"Friend A","year":"2023","unstructured":"Friend A, Settelmeyer TP, Girzadas D. Acute Chest Syndrome. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn HF","year":"1997","unstructured":"Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997, 337:762-769. 10.1056\/NEJM199709113371107","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198005013021803","article-title":"Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity","volume":"302","author":"Hebbel RP","year":"1980","unstructured":"Hebbel RP, Boogaerts MA, Eaton JW, Steinberg MH. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med. 1980, 302:992-995. 10.1056\/NEJM198005013021803","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V68.5.1162.1162","article-title":"Vaso-occlusion by sickle cells: evidence for selective trapping of dense red cells","volume":"68","author":"Kaul DK","year":"1986","unstructured":"Kaul DK, Fabry ME, Nagel RL. Vaso-occlusion by sickle cells: evidence for selective trapping of dense red cells. Blood. 1986, 68:1162-1166. 10.1182\/blood.V68.5.1162.1162","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/pr10050927","article-title":"Continuous-flow magnetic fractionation of red blood cells based on hemoglobin content and oxygen saturation\u2014 clinical blood supply implications and sickle cell anemia treatment","volume":"10","author":"Weigand M","year":"2022","unstructured":"Weigand M, Gomez-Pastora J, Palmer A, Zborowski M, Desai P, Chalmers J. Continuous-flow magnetic fractionation of red blood cells based on hemoglobin content and oxygen saturation\u2014 clinical blood supply implications and sickle cell anemia treatment. Processes. 2022, 10:927. 10.3390\/pr10050927","journal-title":"Processes"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-204990","article-title":"The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice","volume":"115","author":"Hebbel RP","year":"2010","unstructured":"Hebbel RP, Vercellotti GM, Pace BS, et al.. The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice. Blood. 2010, 115:2483-2490. 10.1182\/blood-2009-02-204990","journal-title":"Blood"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2019.02.018","article-title":"Sickle cell disease and stroke","volume":"95","author":"Hirtz D","year":"2019","unstructured":"Hirtz D, Kirkham FJ. Sickle cell disease and stroke. Pediatr Neurol. 2019, 95:34-41. 10.1016\/j.pediatrneurol.2019.02.018","journal-title":"Pediatr Neurol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.10.900","article-title":"Cardiovascular abnormalities in sickle cell disease","volume":"59","author":"Gladwin MT","year":"2012","unstructured":"Gladwin MT, Sachdev V. Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol. 2012, 59:1123-1133. 10.1016\/j.jacc.2011.10.900","journal-title":"J Am Coll Cardiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1099069","article-title":"Chronic anemia is associated with systemic endothelial dysfunction","volume":"10","author":"Chennupati R","year":"2023","unstructured":"Chennupati R, Solga I, Wischmann P, et al.. Chronic anemia is associated with systemic endothelial dysfunction. Front Cardiovasc Med. 2023, 10:10.3389\/fcvm.2023.1099069","journal-title":"Front Cardiovasc Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34003","article-title":"Pediatric sickle cell disease and stroke: a literature review","volume":"15","author":"Parikh T","year":"2023","unstructured":"Parikh T, Goti A, Yashi K, Ravikumar NPG, Parmar N, Dankhara N, Satodiya V. Pediatric sickle cell disease and stroke: a literature review. Cureus. 2023, 15:e34003. 10.7759\/cureus.34003","journal-title":"Cureus"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230204","article-title":"Brain infarction in sickle cell anemia: magnetic resonance imaging correlates","volume":"23","author":"Pavlakis SG","year":"1988","unstructured":"Pavlakis SG, Bello J, Prohovnik I, et al.. Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Ann Neurol. 1988, 23:125-130. 10.1002\/ana.410230204","journal-title":"Ann Neurol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd P","year":"2019","unstructured":"Sundd P, Gladwin MT, Novelli EM. Pathophysiology of sickle cell disease. Annu Rev Pathol. 2019, 14:263-292. 10.1146\/annurev-pathmechdis-012418-012838","journal-title":"Annu Rev Pathol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1278326","article-title":"Atherosclerosis in sickle cell disease \u2014 a review","volume":"18","author":"Elsharawy MA","year":"2009","unstructured":"Elsharawy MA, Moghazy KM, Shawarby MA. Atherosclerosis in sickle cell disease \u2014 a review. Int J Angiol. 2009, 18:62-66. 10.1055\/s-0031-1278326","journal-title":"Int J Angiol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05701.x","article-title":"Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality","volume":"130","author":"Kato GJ","year":"2005","unstructured":"Kato GJ, Martyr S, Blackwelder WC, et al.. Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br J Haematol. 2005, 130:943-953. 10.1111\/j.1365-2141.2005.05701.x","journal-title":"Br J Haematol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.39.3.344","article-title":"Cerebral hyperemia, stroke, and transfusion in sickle cell disease","volume":"39","author":"Prohovnik I","year":"1989","unstructured":"Prohovnik I, Pavlakis SG, Piomelli S, Bello J, Mohr JP, Hilal S, De Vivo DC. Cerebral hyperemia, stroke, and transfusion in sickle cell disease. Neurology. 1989, 39:344-348. 10.1212\/wnl.39.3.344","journal-title":"Neurology"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34314","article-title":"Moyamoya syndrome (MMS) in a patient with sickle cell disease (SCD) and protein S deficiency","volume":"15","author":"Saxena P","year":"2023","unstructured":"Saxena P, Alkaissi H, Chauhan R, Muthu J. Moyamoya syndrome (MMS) in a patient with sickle cell disease (SCD) and protein S deficiency. Cureus. 2023, 15:e34314. 10.7759\/cureus.34314","journal-title":"Cureus"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80897-2","article-title":"Stroke in a cohort of patients with homozygous sickle cell disease","volume":"120","author":"Balkaran B","year":"1992","unstructured":"Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr. 1992, 120:360-366. 10.1016\/S0022-3476(05)80897-2","journal-title":"J Pediatr"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2014.01.005","article-title":"Cerebral vasculopathy in pediatric sickle-cell anemia (Article in French)","volume":"21","author":"Kossorotoff M","year":"2014","unstructured":"Kossorotoff M, Grevent D, de Montalembert M. Cerebral vasculopathy in pediatric sickle-cell anemia (Article in French). Arch Pediatr. 2014, 21:404-414. 10.1016\/j.arcped.2014.01.005","journal-title":"Arch Pediatr"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.13113","article-title":"Intelligence quotient in paediatric sickle cell disease: a systematic review and meta-analysis","volume":"58","author":"Kawadler JM","year":"2016","unstructured":"Kawadler JM, Clayden JD, Clark CA, Kirkham FJ. Intelligence quotient in paediatric sickle cell disease: a systematic review and meta-analysis. Dev Med Child Neurol. 2016, 58:672-679. 10.1111\/dmcn.13113","journal-title":"Dev Med Child Neurol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2017.04.023","article-title":"Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients","volume":"15","author":"Choi S","year":"2017","unstructured":"Choi S, Bush AM, Borzage MT, et al.. Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients. Neuroimage Clin. 2017, 15:239-246. 10.1016\/j.nicl.2017.04.023","journal-title":"Neuroimage Clin"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.308398","article-title":"Stroke risk factors, genetics, and prevention","volume":"120","author":"Boehme AK","year":"2017","unstructured":"Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics, and prevention. Circ Res. 2017, 120:472-495. 10.1161\/CIRCRESAHA.116.308398","journal-title":"Circ Res"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.308441","article-title":"Stroke caused by atherosclerosis of the major intracranial arteries","volume":"120","author":"Banerjee C","year":"2017","unstructured":"Banerjee C, Chimowitz MI. Stroke caused by atherosclerosis of the major intracranial arteries. Circ Res. 2017, 120:502-513. 10.1161\/CIRCRESAHA.116.308441","journal-title":"Circ Res"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/jon.12766","article-title":"Neuroimaging in sickle cell disease: a review","volume":"30","author":"Mallon D","year":"2020","unstructured":"Mallon D, Doig D, Dixon L, Gontsarova A, Jan W, Tona F. Neuroimaging in sickle cell disease: a review. J Neuroimaging. 2020, 30:725-735. 10.1111\/jon.12766","journal-title":"J Neuroimaging"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-694562","article-title":"Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia","volume":"127","author":"Kassim AA","year":"2016","unstructured":"Kassim AA, Pruthi S, Day M, et al.. Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia. Blood. 2016, 127:2038-2040. 10.1182\/blood-2016-01-694562","journal-title":"Blood"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-009506","article-title":"Stroke prevention trial in sickle cell anemia (STOP): extended follow-up and final results","volume":"108","author":"Lee MT","year":"2006","unstructured":"Lee MT, Piomelli S, Granger S, Miller ST, Harkness S, Brambilla DJ, Adams RJ. Stroke prevention trial in sickle cell anemia (STOP): extended follow-up and final results. Blood. 2006, 108:847-852. 10.1182\/blood-2005-10-009506","journal-title":"Blood"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial Doppler flow velocities in children with sickle cell anaemia-TCD with transfusions changing to hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"Ware RE","year":"2016","unstructured":"Ware RE, Davis BR, Schultz WH, et al.. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial Doppler flow velocities in children with sickle cell anaemia-TCD with transfusions changing to hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2016, 387:661-670. 10.1016\/S0140-6736(15)01041-7","journal-title":"Lancet"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-325258","article-title":"Fetal hemoglobin in sickle cell anemia","volume":"118","author":"Akinsheye I","year":"2011","unstructured":"Akinsheye I, Alsultan A, Solovieff N, et al.. Fetal hemoglobin in sickle cell anemia. Blood. 2011, 118:19-27. 10.1182\/blood-2011-03-325258","journal-title":"Blood"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.271353","article-title":"Chronic organ injuries in children with sickle cell disease","volume":"106","author":"Allali S","year":"2021","unstructured":"Allali S, Taylor M, Brice J, de Montalembert M. Chronic organ injuries in children with sickle cell disease. Haematologica. 2021, 106:1535-1544. 10.3324\/haematol.2020.271353","journal-title":"Haematologica"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.4103\/ajts.AJTS_101_18","article-title":"A case series of hemorrhagic neurological complications of sickle cell disease: multiple faces of an underestimated problem!","volume":"15","author":"Kamath SD","year":"2021","unstructured":"Kamath SD, Pai MG. A case series of hemorrhagic neurological complications of sickle cell disease: multiple faces of an underestimated problem!. Asian J Transfus Sci. 2021, 15:241-246. 10.4103\/ajts.AJTS_101_18","journal-title":"Asian J Transfus Sci"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000940","article-title":"Bleeding in patients with sickle cell disease: a population-based study","volume":"4","author":"Hariharan N","year":"2020","unstructured":"Hariharan N, Brunson A, Mahajan A, Keegan TH, Wun T. Bleeding in patients with sickle cell disease: a population-based study. Blood Adv. 2020, 4:793-802. 10.1182\/bloodadvances.2019000940","journal-title":"Blood Adv"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2006.09.017","article-title":"Hemorrhagic stroke in children","volume":"36","author":"Jordan LC","year":"2007","unstructured":"Jordan LC, Hillis AE. Hemorrhagic stroke in children. Pediatr Neurol. 2007, 36:73-80. 10.1016\/j.pediatrneurol.2006.09.017","journal-title":"Pediatr Neurol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2016.00864","article-title":"Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update","volume":"19","author":"An SJ","year":"2017","unstructured":"An SJ, Kim TJ, Yoon BW. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke. 2017, 19:3-10. 10.5853\/jos.2016.00864","journal-title":"J Stroke"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato GJ","year":"2017","unstructured":"Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest. 2017, 127:750-760. 10.1172\/JCI89741","journal-title":"J Clin Invest"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.26443\/mjm.v9i2.672","article-title":"An overview of intracranial aneurysms","volume":"9","author":"Keedy A","year":"2006","unstructured":"Keedy A. An overview of intracranial aneurysms. McGill J Med. 2006, 9:141-146. 10.26443\/mjm.v9i2.672","journal-title":"McGill J Med"},{"key":"ref75","article-title":"","author":"Koutsothanasis GA","year":"2023","unstructured":"Koutsothanasis GA, Sampath R. Berry Aneurysm. StatPearls Publishing, Treasure Island, FL; 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557480\/."},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"46","author":"Hemphill JC 3rd","year":"2015","unstructured":"Hemphill JC 3rd, Greenberg SM, Anderson CS, et al.. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2015, 46:2032-2060. 10.1161\/STR.0000000000000069","journal-title":"Stroke"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2016.06.010","article-title":"Diagnosis and management of acute intracerebral hemorrhage","volume":"34","author":"Morotti A","year":"2016","unstructured":"Morotti A, Goldstein JN. Diagnosis and management of acute intracerebral hemorrhage. Emerg Med Clin North Am. 2016, 34:883-899. 10.1016\/j.emc.2016.06.010","journal-title":"Emerg Med Clin North Am"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-0922-0_5","article-title":"Sickle-cell disease and stroke","author":"Krejza J","year":"2009","unstructured":"Krejza J, Swiat M, Tomaszewski M, Melhem ER. Sickle-cell disease and stroke. Evidence-Based Imaging in Pediatrics. Medina L, Applegate K, Blackmore C (ed): Springer, New York; 2009. 10.1007\/978-1-4419-0922-0_5"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijans.2015.08.002","article-title":"Sickle cell disease among children in Africa: an integrative literature review and global recommendations","volume":"3","author":"Mulumba LL","year":"2015","unstructured":"Mulumba LL, Wilson L. Sickle cell disease among children in Africa: an integrative literature review and global recommendations. Int J Africa Nurs Sci. 2015, 3:56-64. 10.1016\/j.ijans.2015.08.002","journal-title":"Int J Africa Nurs Sci"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.540112","article-title":"Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors","volume":"40","author":"Andersen KK","year":"2009","unstructured":"Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke. 2009, 40:2068-2072. 10.1161\/STROKEAHA.108.540112","journal-title":"Stroke"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke with transfusions changing to hydroxyurea (SWiTCH)","volume":"119","author":"Ware RE","year":"2012","unstructured":"Ware RE, Helms RW. Stroke with transfusions changing to hydroxyurea (SWiTCH). Blood. 2012, 119:3925-3932. 10.1182\/blood-2011-11-392340","journal-title":"Blood"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10184232","article-title":"Epidemiology of stroke in sickle cell disease","volume":"10","author":"Kirkham FJ","year":"2021","unstructured":"Kirkham FJ, Lagunju IA. Epidemiology of stroke in sickle cell disease. J Clin Med. 2021, 10:10.3390\/jcm10184232","journal-title":"J Clin Med"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229959","article-title":"Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: a systematic literature review and meta-analysis","volume":"15","author":"Ataga KI","year":"2020","unstructured":"Ataga KI, Gordeuk VR, Agodoa I, Colby JA, Gittings K, Allen IE. Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: a systematic literature review and meta-analysis. PLoS One. 2020, 15:e0229959. 10.1371\/journal.pone.0229959","journal-title":"PLoS One"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.11.61","article-title":"The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease","volume":"4","author":"Strouse JJ","year":"2011","unstructured":"Strouse JJ, Lanzkron S, Urrutia V. The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease. Expert Rev Hematol. 2011, 4:597-606. 10.1586\/ehm.11.61","journal-title":"Expert Rev Hematol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.03.013","article-title":"Diagnosis and management of pediatric arterial ischemic stroke","volume":"19","author":"Lopez-Vicente M","year":"2010","unstructured":"Lopez-Vicente M, Ortega-Gutierrez S, Amlie-Lefond C, Torbey MT. Diagnosis and management of pediatric arterial ischemic stroke. J Stroke Cerebrovasc Dis. 2010, 19:175-183. 10.1016\/j.jstrokecerebrovasdis.2009.03.013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3885979","article-title":"Sickle cell disease in children and adolescents: a review of the historical, clinical, and public health perspective of sub-saharan africa and beyond","volume":"2022","author":"Egesa WI","year":"2022","unstructured":"Egesa WI, Nakalema G, Waibi WM, et al.. Sickle cell disease in children and adolescents: a review of the historical, clinical, and public health perspective of sub-saharan africa and beyond. Int J Pediatr. 2022, 2022:3885979. 10.1155\/2022\/3885979","journal-title":"Int J Pediatr"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.4236\/nm.2019.102011","article-title":"Transcranial Doppler ultrasonography to prevent cerebrovascular accident in children with sickle-cell disease","volume":"10","author":"Carpentieri-Pipolo G","year":"2019","unstructured":"Carpentieri-Pipolo G, Oliveira MDL, Paulo S. Transcranial Doppler ultrasonography to prevent cerebrovascular accident in children with sickle-cell disease. Neurosci Med. 2019, 10:162-173. 10.4236\/nm.2019.102011","journal-title":"Neurosci Med"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: a review","volume":"328","author":"Kavanagh PL","year":"2022","unstructured":"Kavanagh PL, Fasipe TA, Wun T. Sickle cell disease: a review. JAMA. 2022, 328:57-68. 10.1001\/jama.2022.10233","journal-title":"JAMA"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1177\/09727531221108871","article-title":"Neurocognitive changes in sickle cell disease: a comprehensive review","volume":"29","author":"Sahu T","year":"2022","unstructured":"Sahu T, Pande B, Sinha M, Sinha R, Verma HK. Neurocognitive changes in sickle cell disease: a comprehensive review. Ann Neurosci. 2022, 29:255-268. 10.1177\/09727531221108871","journal-title":"Ann Neurosci"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01237-z","article-title":"Advances in the diagnosis and treatment of sickle cell disease","volume":"15","author":"Brandow AM","year":"2022","unstructured":"Brandow AM, Liem RI. Advances in the diagnosis and treatment of sickle cell disease. J Hematol Oncol. 2022, 15:20. 10.1186\/s13045-022-01237-z","journal-title":"J Hematol Oncol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjhh.2017.08.008","article-title":"Genetic, laboratory and clinical risk factors in the development of overt ischemic stroke in children with sickle cell disease","volume":"40","author":"Belis\u00e1rio AR","year":"2018","unstructured":"Belis\u00e1rio AR, Silva CM, Velloso-Rodrigues C, Viana MB. Genetic, laboratory and clinical risk factors in the development of overt ischemic stroke in children with sickle cell disease. Hematol Transfus Cell Ther. 2018, 40:166-181. 10.1016\/j.bjhh.2017.08.008","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.11.003","article-title":"Hypertension and cardiovascular risk: general aspects","volume":"129","author":"Kjeldsen SE","year":"2018","unstructured":"Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. 2018, 129:95-99. 10.1016\/j.phrs.2017.11.003","journal-title":"Pharmacol Res"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000204041.13466.4c","article-title":"Distinguishing between stroke and mimic at the bedside: the brain attack study","volume":"37","author":"Hand PJ","year":"2006","unstructured":"Hand PJ, Kwan J, Lindley RI, Dennis MS, Wardlaw JM. Distinguishing between stroke and mimic at the bedside: the brain attack study. Stroke. 2006, 37:769-775. 10.1161\/01.STR.0000204041.13466.4c","journal-title":"Stroke"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-012-0185-9","article-title":"Comparison of CT and MR imaging in ischemic stroke","volume":"3","author":"Vymazal J","year":"2012","unstructured":"Vymazal J, Rulseh AM, Keller J, Janouskova L. Comparison of CT and MR imaging in ischemic stroke. Insights Imaging. 2012, 3:619-627. 10.1007\/s13244-012-0185-9","journal-title":"Insights Imaging"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2021.1893687","article-title":"MRI detection of brain abnormality in sickle cell disease","volume":"14","author":"Stotesbury H","year":"2021","unstructured":"Stotesbury H, Kawadler JM, Saunders DE, Kirkham FJ. MRI detection of brain abnormality in sickle cell disease. Expert Rev Hematol. 2021, 14:473-491. 10.1080\/17474086.2021.1893687","journal-title":"Expert Rev Hematol"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.841809","article-title":"Transcranial Doppler ultrasonography as a diagnostic tool for cerebrovascular disorders","volume":"16","author":"Pan Y","year":"2022","unstructured":"Pan Y, Wan W, Xiang M, Guan Y. Transcranial Doppler ultrasonography as a diagnostic tool for cerebrovascular disorders. Front Hum Neurosci. 2022, 16:841809. 10.3389\/fnhum.2022.841809","journal-title":"Front Hum Neurosci"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.192616","article-title":"Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association","volume":"40","author":"Latchaw RE","year":"2009","unstructured":"Latchaw RE, Alberts MJ, Lev MH, et al.. Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke. 2009, 40:3646-3678. 10.1161\/STROKEAHA.108.192616","journal-title":"Stroke"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X17721830","article-title":"Consensus statement on current and emerging methods for the diagnosis and evaluation of cerebrovascular disease","volume":"38","author":"Donahue MJ","year":"2018","unstructured":"Donahue MJ, Achten E, Cogswell PM, et al.. Consensus statement on current and emerging methods for the diagnosis and evaluation of cerebrovascular disease. J Cereb Blood Flow Metab. 2018, 38:1391-1417. 10.1177\/0271678X17721830","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31778","article-title":"Blood transfusion vs. Hydroxyurea for stroke prevention in children with sickle cell anemia: a systematic review and meta-analysis","volume":"14","author":"Hafiz TA","year":"2022","unstructured":"Hafiz TA, Aldharman SS, AlSubaie RN, et al.. Blood transfusion vs. Hydroxyurea for stroke prevention in children with sickle cell anemia: a systematic review and meta-analysis. Cureus. 2022, 14:e31778. 10.7759\/cureus.31778","journal-title":"Cureus"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S383472","article-title":"Managing the cerebrovascular complications of sickle cell disease: current perspectives","volume":"14","author":"Light J","year":"2023","unstructured":"Light J, Boucher M, Baskin-Miller J, Winstead M. Managing the cerebrovascular complications of sickle cell disease: current perspectives\r\n. J Blood Med. 2023, 14:279-293. 10.2147\/JBM.S383472","journal-title":"J Blood Med"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.270546","article-title":"Red cell transfusion and alloimmunization in sickle cell disease","volume":"106","author":"Linder GE","year":"2021","unstructured":"Linder GE, Chou ST. Red cell transfusion and alloimmunization in sickle cell disease. Haematologica. 2021, 106:1805-1815. 10.3324\/haematol.2020.270546","journal-title":"Haematologica"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.05.003","article-title":"Blood pressure management after mechanical thrombectomy for acute ischemic stroke: a survey of the strokenet sites","volume":"27","author":"Mistry EA","year":"2018","unstructured":"Mistry EA, Mayer SA, Khatri P. Blood pressure management after mechanical thrombectomy for acute ischemic stroke: a survey of the strokenet sites. J Stroke Cerebrovasc Dis. 2018, 27:2474-2478. 10.1016\/j.jstrokecerebrovasdis.2018.05.003","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrleng.2011.09.012","article-title":"Guidelines for the treatment of acute ischaemic stroke","volume":"29","author":"de Leci\u00f1ana MA","year":"2014","unstructured":"de Leci\u00f1ana MA, Egido JA, Casado I, et al.. Guidelines for the treatment of acute ischaemic stroke. Neurologia. 2014, 29:102-122. 10.1016\/j.nrleng.2011.09.012","journal-title":"Neurologia"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.099747","article-title":"Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel","volume":"99","author":"Angelucci E","year":"2014","unstructured":"Angelucci E, Matthes-Martin S, Baronciani D, et al.. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica. 2014, 99:811-820. 10.3324\/haematol.2013.099747","journal-title":"Haematologica"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24235","article-title":"Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: the last 40 years","volume":"91","author":"Chaturvedi S","year":"2016","unstructured":"Chaturvedi S, DeBaun MR. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: the last 40 years. Am J Hematol. 2016, 91:5-14. 10.1002\/ajh.24235","journal-title":"Am J Hematol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1104101","article-title":"Rehabilitation: a key service, yet highly underused, in the management of young patients with sickle cell disease after stroke in DR of Congo","volume":"14","author":"Boma PM","year":"2023","unstructured":"Boma PM, Panda J, Mande JPN, Bonnech\u00e8re B. Rehabilitation: a key service, yet highly underused, in the management of young patients with sickle cell disease after stroke in DR of Congo. Front Neurol. 2023, 14:1104101. 10.3389\/fneur.2023.1104101","journal-title":"Front Neurol"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn BP","year":"2014","unstructured":"Yawn BP, Buchanan GR, Afenyi-Annan AN, et al.. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014, 312:1033-1048. 10.1001\/jama.2014.10517","journal-title":"JAMA"},{"key":"ref108","article-title":"Management of Acute Complications of Sickle Cell Disease A Pocket Guide for the Clinician","author":"Desai P","year":"2014","unstructured":"Desai P. Management of Acute Complications of Sickle Cell Disease A Pocket Guide for the Clinician. American Society of Hematology, Washington, DC; 2014."},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.8.2.291","article-title":"Need for cognitive rehabilitation for children with sickle cell disease and strokes","volume":"8","author":"King AA","year":"2008","unstructured":"King AA, DeBaun MR, White DA. Need for cognitive rehabilitation for children with sickle cell disease and strokes. Expert Rev Neurother. 2008, 8:291-296. 10.1586\/14737175.8.2.291","journal-title":"Expert Rev Neurother"},{"key":"ref110","article-title":"","author":"Tadi P","year":"2023","unstructured":"Tadi P, Lui F, Budd LA. Acute Stroke (Nursing). StatPearls Publishing, Treasure Island, FL; 2023. https:\/\/europepmc.org\/article\/NBK\/nbk568693."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/208654-overview-of-the-association-between-the-pathophysiology-types-and-management-of-sickle-cell-disease-and-stroke","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:38Z","timestamp":1707509378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/208654-overview-of-the-association-between-the-pathophysiology-types-and-management-of-sickle-cell-disease-and-stroke"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":110,"URL":"https:\/\/doi.org\/10.7759\/cureus.50577","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}